Deep Semi Supervised Generative Learning for Automated Tumor Proportion Scoring on NSCLC Tissue Needle Biopsies
Author:
Publisher
Springer Science and Business Media LLC
Subject
Multidisciplinary
Link
http://www.nature.com/articles/s41598-018-35501-5.pdf
Reference51 articles.
1. Zou, W., Wolchok, J. D. & Chen, L. Pd-l1 (b7-h1) and pd-1 pathway blockade for cancer therapy: Mechanisms, response biomarkers, and combinations. Sci. translational medicine 8, 328rv4–328rv4 (2016).
2. Grigg, C. & Rizvi, N. A. Pd-l1 biomarker testing for non-small cell lung cancer: truth or fiction? J. for immunotherapy cancer 4, 48 (2016).
3. Udall, M. et al. Pd-l1 diagnostic tests: a systematic literature review of scoring algorithms and test-validation metrics. Diagn. pathology 13, 12 (2018).
4. Kim, H., Kwon, H. J., Park, S. Y., Park, E. & Chung, J.-H. Pd-l1 immunohistochemical assays for assessment of therapeutic strategies involving immune checkpoint inhibitors in non-small cell lung cancer: a comparative study. Oncotarget 8, 98524 (2017).
5. Hirsch, F. R. et al. Pd-l1 Immunohistochemistry assays for lung cancer: results from phase 1 of the blueprint pd-l1 ihc assay comparison project. J. Thorac. Oncol. 12, 208–222 (2017).
Cited by 79 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. A Deep Learning–Based Assay for Programmed Death Ligand 1 Immunohistochemistry Scoring in Non–Small Cell Lung Carcinoma: Does it Help Pathologists Score?;Modern Pathology;2024-06
2. A Pipeline for Evaluation of Machine Learning/Artificial Intelligence Models to Quantify Programmed Death Ligand 1 Immunohistochemistry;Laboratory Investigation;2024-06
3. Clinical Validation of Artificial Intelligence–Powered PD-L1 Tumor Proportion Score Interpretation for Immune Checkpoint Inhibitor Response Prediction in Non–Small Cell Lung Cancer;JCO Precision Oncology;2024-05
4. Automated Quantification of DNA Damage Using Deep Learning and Use of Synthetic Data Generated from Basic Geometric Shapes;ECS Sensors Plus;2024-02-07
5. An automatic Darknet-based immunohistochemical scoring system for IL-24 in lung cancer;Engineering Applications of Artificial Intelligence;2024-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3